DIA 2013 49th Annual Meeting
Click here to go to the previous page
Current Regulatory Landscape Impacting Medical and Scientific Communications
Track
:
Track 19: Communities Showcase
Program Code:
388
Date:
Wednesday, June 26, 2013
Time:
4:00 PM to 5:30 PM
EST
Location:
205A
CHAIR
:
Mary K Sendi, PharmD (SCHNON), Director and Team Lead, Medical Information, Pfizer Inc, United States
SPEAKER
(S):
Melissa L. Harris, PharmD (SPKNON), Executive Director, US Medical Information and Field Medical Operations, Bristol-Myers Squibb Company, United States
Stuart Sowder, JD,PharmD,MBA (SPKNON), Vice President, External Medical Communications, Pfizer Inc, United States
Description
This session will address how FDA regulatory guidance documents affect the pharmaceutical industry, impacting how externally-facing medical functions communicate medical and scientific information to health care professionals and consumers.
This session has been developed by the Medical Communications Community.
This session has been developed by the Medical Communications Community.
This session is a part of:
This session is a part of: